TXG- 10x Genomics, Inc.

Name: 10x Genomics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

10x Genomics, Inc. (TXG) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 45 sells. TXG is classified in the Health Care Technology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Saxonov Serge	1.07M	$30.90M	-
Other	Hindson Benjamin J.	432.6K	$12.48M	-
Dir	Stuelpnagel John R	368.4K	$10.63M	-
CFO	Taich Adam	297.4K	$8.58M	-
Dir	Mateo Alan	85.9K	$2.48M	-

Activity

Buys and sells only

Transactions

10 filings · page 18

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jan 4, 2021	Stuelpnagel John R89	Director	Sell	7,500	$139.86	$1,048,981.81	-0.4%
Jan 4, 2021	Saxonov Serge80	Chief Executive Officer	Sale+OE	10,000	$139.93	$1,399,261.54	-0.3%
Jan 4, 2021	McAnear Justin J.84	Chief Financial Officer	Sale+OE	10,000	$139.94	$1,399,390.13	-9.7%
Jan 4, 2021	Crutchfield Bradford87	Chief Commercial Officer	Sale+OE	17,000	$139.93	$2,378,773.48	-9.8%
Jan 4, 2021	Hindson Benjamin J.82	See Remarks	Sell	33,750	$139.93	$4,722,800.77	-9.5%
Dec 16, 2020	Stuelpnagel John R89	Director	Sell	7,500	$148.21	$1,111,583.09	-0.3%
Dec 1, 2020	McAnear Justin J.84	Chief Financial Officer	Sale+OE	10,000	$151.46	$1,514,611.59	-34.1%
Dec 1, 2020	Hindson Benjamin J.82	See Remarks	Sale+OE	33,750	$151.32	$5,107,148.12	-8.1%
Dec 1, 2020	Crutchfield Bradford87	Chief Commercial Officer	Sale+OE	17,000	$151.29	$2,571,982.33	-37.0%
Dec 1, 2020	Stuelpnagel John R89	Director	Sell	7,500	$151.23	$1,134,228.29	-0.3%

← PrevPage 18Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC